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Abstract 
Human lactase-phlorizin hydrolase (LPH, EC 3.2.1.23/62) is synthesized as a single-chain precursor glycoprotein (pro-LPH) with a 
relative molecular mass of just over 200 kDa. Maturation to the mature enzyme (m-LPH, 160 kDa) occurs after passage of pro-LPH 
through the Golgi complex and involves the proteolytic removal of a 849 amino acid propeptide. The role of this propeptide as well as its 
removal is not fully understood and the proteolytic enzyme or enzymes involved are unknown. We studied the potential role of five 
different members of the family of subtilisin-like proprotein processing proteases in the maturation process of human LPH using a 
vaccinia virus based coexpression system in pig kidney PK(15) cells. Infected/transfected PK(15) cells expressed full-length pro-LPH 
but no maturation to m-LPH was observed. Coexpression of human pro-LPH with human furin, human PC1/PC3, human PC2, human 
PACE4 and mouse PC6A in PK(15) cells did not result in maturation of the enzyme. Cleavage and secretion of von Willebrand factor 
precursor (pro-vWF) was used as a positive control. None of the five proprotein processing proteases tested were capable of cleaving 
human pro-LPH, strongly suggesting that they are not involved in the maturation of this enzyme. 
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1. Introduct ion 
Small intestinal lactase-phlorizin hydrolase (LPH) (EC 
3.2.1.23/62) is responsible for the hydrolysis of  lactose 
during the suckling period. The structure of  rabbit and 
human LPH has been elucidated [1]. LPH is synthesized in 
a pre-pro form in the lumen of the ER, where the N-termi- 
nal signal peptide is removed. The pro-LPH (M r - - 2 1 5 -  
245 kDa) is proteolytically processed during transport to 
the microvillus membrane domain to yield the mature 
enzyme ( M r =  160 kDa) [2-5]. The mature enzyme is 
inserted into the microvillus membrane as a type I mem- 
Abbreviations: LPH, lactase-.phlorizin hydrolase; vWF, yon Wille- 
brand factor; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis; NP40, Nonidet ]?40; DOC, sodium deoxycholate; PBS, 
phosphate-buffered saline; DEAE-dextran, o-(dimethylaminoethyl)-de- 
xtran; endo H, endoglycosidase It; PC, prohormone convertase. 
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brane protein. Biosynthetic studies in Caco-2 [6], trans- 
fected MDCK cells [7], and organ-cultured human small 
intestinal explants [8] have clearly shown that proteolytic 
processing occurs after passage of pro-LPH through the 
Golgi complex. 
A whole family of processing proteases has emerged in 
recent years, which are involved in maturation of  bioactive 
peptides and proteins. The first enzyme of this novel 
family to be described was the Kexin (EC 3.4.21.61) 
protease of  yeast Saccharomyces cerevisiae. Kexin is a 
Ca 2÷- dependent serine protease with a subtilisin-like cat- 
alytic domain, and is responsible for the processing of the 
pro-a-factor at dibasic sites [9]. Recently, seven mam- 
malian Kexin homologues, furin [10-12], PC2 [13-16] and 
P C I / 3  [14,16-20] PC4 [21], PACE4 [22], PC6A [23] and 
PC6B [24] have been identified by cDNA cloning. Tissue 
distribution of  these processing endoproteases demon- 
strated a unique pattern for each enzyme [13-  
17,19,21,23,25]. PC2 and P C 1 / 3  preferentially cleave af- 
ter a pair of basic residues, Lys-Arg or Arg-Arg [26]. Furin 
200 M. Wiithrich et al. / Biochimica et Biophysica Acta 1311 (1996) 199-203 
on the other hand has been shown to be involved in 
precursor cleavage at the consensus sequence Arg-X- 
Arg/Lys-Arg (RXK/RR) [27,28], but is also capable of 
cleaving the minimal cleavage site Arg-X-X-Arg (RXXR) 
[29,30]. 
The N-terminal Ala (Alas69) [1] of mature LPH from 
human small intestine is preceded by an Arg residue 
(Arg868) and thus constitutes a typical trypsin-like cleav- 
age site. An identical Arg-Ala site is present in rabbit LPH 
[31,32]. In addition, pro-LPH contains potential cleavage 
sites for furin-like processing proteases upstream from the 
N-terminal amino acid residue of mature LPH. There is a 
potent ia l  furin mo t i f  ( R X X R )  at pos i t ions  
R829T830Ps31R832 . R832 is also part of a dibasic site 
(Args32Lys833) and an additional dibasic site is present at 
positions Lyss53Arg854 . There are also monobasic sites at 
positions Arg844, Args5 o, Lys866 and the Arg868 immedi- 
ately in front of the N-terminal Alas69 of m-LPH. It is thus 
conceivable that pro-LPH is cleaved at one of these sites 
before the poly-peptide is further trimmed by an exopepti- 
dase to yield the mature LPH which may be isolated from 
the enterocyte microvillus membrane. 
In this paper, we report the coexpression of a full-length 
cDNA for human pro-LPH together with cDNA for human 
furin, PC2, PC1/PC3, PACE4 and mouse PC6A in pig 
kidney PK(15) cell lines in order to test the ability of these 
proprotein processing enzymes to cleave this precursor 
molecule. 
2. Materials and methods 
Recombinant vaccinia virus V.V.:T7 produces T7 RNA 
polymerase [35]. After infection, medium was replaced 
with fresh medium containing 4 #g DNA and DOTAP 
transfection-reagent (Boehringer Mannheim Biochemical). 
Lipofectamine-mediated transfection was for 16-18 h ac- 
cording to the suppliers instructions. 
2.3. Metabolic labelling of PK(15) cells 
Biosynthesis and processing of pro-vWF- and pro-LPH 
substrates were studied 16-18 h after cotransfection with 
the different proprotein processing proteases. Prior to la- 
belling of PK(15) cells, medium was removed and cells 
were incubated for 1 h in RPMI medium that lacked 
methionine. Subsequently, cells were labelled for 30 rain 
in the presence of [35S]methionine (100 /xCi/ml, spec. 
act. 800 Ci/mmol) (Du Pont NEN), followed by a chase 
of 4 h with unlabelled methionine (final concentration i 
mM). In the case of the vWF samples, the medium was 
spun down for 5 min at 3000 rpm and then concentrated 
by TCA-precipitation in the presence of bovine serum 
albumin (50 /xg/ml). Human LPH was immunoprecip- 
itated from lysed PK15 cells as described below. 
2.4. Culture and metabolic labelling of Caco-2 cells 
Caco-2 cells were cultured as previously described [6]. 
Metabolic labelling with 150 /xCi of L-[35S]methionine 
was continuous for 30 rain and 24 h, respectively. Labelled 
LPH was immunoprecipitated and analyzed by SDS-PAGE 
as described. 
2.1. Plasmids and cDNAs 2.5. Immunoprecipitation of human LPH 
The full length cDNA coding for human LPH (kindly 
provided by Dr. Ned Mantei and Rahel B~inzinger, Swiss 
Federal Institute of Technology, Ziirich) [1] was subcloned 
in pGEM3Zf + (Promega). Human von Willebrand factor 
cDNAs (kindly provided by Dr. van Mourik, Central Lab- 
oratory of the Netherlands Red Cross Blood Transfusion 
Service) were cloned in pGEM7zf + [29,33]. Recombinant 
cDNA constructs coding for human furin, human 
PC1/PC3, human PC2, human PACE4 and mouse PC6A 
under the control of the T7 promoter, have been described 
elsewhere [12,34,17,22,23,33] and were cloned in 
pGEM3Zf + or 13Zf +. 
2.2. Culture, infection and transfection of cells 
Pig kidney PK(15) cells were propagated in DMEM 
(Gibco BRL) supplemented with foetal calf serum (10% 
v / v )  (Biological Industries), glutamine (2 mM) and antibi- 
otics (penicillin (100 U/ml)  and streptomycin (100 
/xg/ml) (Gibco BRL). Cells were infected for 1 h with 
recombinant vaccinia virus V.V.:T7 at an m.o.i, of 5 in 
medium containing bovine serum albumin (20 /xg/ml). 
Labelled PK(15) cells were washed three times with 5 
ml ice-cold PBS and lysed by adding 1 ml of lysis buffer 
(25 mM Tris-HC1, pH 8.0, 50 mM NaCI) supplemented 
with 1% NP 40, 1% DOC, 100 /zg/ml PMSF, 10 /xg/ml 
leupeptin, 2 /xg/ml pepstatin, 34.8 /xg/ml benzamidine, 
and 2 /zg/ml aprotinin (all from Sigma). The lysates were 
spun down at 100000 × g for 30 min prior to immuno- 
precipitation. Solubilized membrane proteins were pre- 
cleared twice with protein A-Sepharose CL-4B beads 
(Pharmacia) and transferred to tubes with 100 /xl of anti- 
body-protein A-Sepharose (containing 3 /xl of the mono- 
clonal antibody against lactase [36]). After an incubation 
period of at least 2 h at 4°C, the beads were washed three 
times with 1 ml PBS containing 0.5% NP-40, 0.05% DOC 
and 0.05% SDS and then twice with 125 mM Tris-HCl 
(pH 8.2), 500 mM NaC1, 1 mM EDTA, 0.5% NP-40. 
2.6. SDS-PAGE 
Immunoprecipitates were solubilized with 30 /xl of 
2-fold concentrated electrophoresis sample buffer contain- 
ing 4% SDS, 20% glycerol, 5% 2-mercaptoethanol or 5 /xl 
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of 2 M M-dithiothreitol (all from BioRad Laboratories), 
boiled for 4 rain and submitted to electrophoresis on 6% 
acrylamide gels according to Laemmli [37]. Molecular 
weight markers were from Sigma. The gels were stained 
with Coomassie blue R250, destained with 40% 
methanol/10% acetic acid, treated with sodium salicylate, 
and exposed to Kodak X-OMAT AR films at -80°C. 
3. Results and discussion 
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Recently obtained evidence from the intestinal Caco-2 
cell line and from polarized MDCK cells transfected with 
human pro-LPH eDNA [7,38] has shown that proteolytic 
cleavage of human pro-LPH is a post-Golgi event, possibly 
occurring in the trans-Golgi network. However, the pro- 
tease or proteases involved still remain unknown. 
To investigate the potential involvement of subtilisin- 
like proprotein processing proteases in the maturation of 
human lactase-phlorizin hydrolase, PK(15) cells were co- 
transfected with pro-LPH eDNA and cDNAs encoding 
human furin (Hufurin), human PC1/PC3 (HuPC1/PC3), 
human PC2 (HuPC2), human PACFA (HuPACE4), and 
mouse PCA (MoPC6A). In parallel control experiments, 
PK(15) cells were transfected with eDNA encoding the 
precursor of von Willebrand factor (pro-vWF) together 
with cDNAs encoding proprotein processing proteases. 
Metabolic labelling of pro-LPH-transfected PK(I 5) cells 
with [35S]methionine for 30 min, followed by a 4 h chase 
resulted in the synthesis of pro-LPH species comparable to 
those in intestinal epithelial cells (Fig. 1A, lanes 2-7). 
For comparison, LPH synthesis in human small intesti- 
nal epithelial cells (Caco-2) yielded a 215 kDa high man- 
nose glycoprotein which was subsequently converted to a 
225 kDa complex glycosylated form (Fig. 1B, lanes 1 and 
2). Proteolytic processing of pro-LPH then resulted in the 
development of the 160 kDa mature LPH found in the 
microvillus membrane (Fig. 1B, lane 2). No mature LPH 
was observed in PK(15)cells transfected with pro-LPH 
cDNA only (Fig. 1A, lane 2). 
None of the cotransfected proprotein processing pro- 
teases human furin, human PC1/PC3, human PC2, human 
PACE4 and mouse PC6A were capable of cleaving the 
expressed pro-LPH in PK(15) cells (Fig. 1A, lanes 3-7). 
Control experiments of infected PK(15) cells transfected 
with the protease cDNAs together with von Willebrand 
factor (pro-vWF) eDNA are shown in Fig. 2. Expression 
of vWF alone resulted in the synthesis and subsequent 
secretion of mainly uncleaved pro-vWF (Fig. 2, lane 2). 
Cotransfection with Hufurin eDNA resulted in a quantita- 
tive conversion of pro-vWF to the mature vWF (Fig. 2, 
lane 3). Insignificant cleavage was observed in cells ex- 
pressing HuPC 1/PC3 (Fig. 2, lane 4) and HuPC2 (Fig. 2, 
lane 5). Although expression of HuPC1/PC3 and HuPC2 
under the experimental conditions used has been verified 
[39] these enzymes exhibited little or no activity towards 
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Fig. 1. (A) Analysis of endoproteolytic processing of human pro-LPH by 
different convertases. PK (15) cells were first infected with recombinant 
vaccinia virus V.V.:T7, which encodes T7 RNA polymerase (lane 1) and 
subsequently cells were lipofected with 2 /xg of pGEMLPH DNA (lane 
2). Other lanes show cotransfection with human furin (lane 3), human 
PCI /PC3 (lane 4), human PC2 (lane 5), human PACE4 (lane 6) and 
mouse PC6A (lane 7). Biosynthesis and processing of LPH-related pro- 
teins were analysed in labelling experiments using [35S]methionine. The 
transfected cells were labelled for 30 rain and subsequently chased for 4 
h. The relative position of pro-LPH and the molecular weight markers are 
indicated. (B) Biosynthetic labelling of LPH in Caco-2 cells. Caco-2 cells 
were labelled with [35S]methionine for 30 min (lane 1) and 24 h (lane 2). 
After the indicated intervals LPH was immunoprecipitated by the mono- 
clonal antibody HBB 1/909/34/74. Immunoprecipitates were subjected 
to SDS-PAGE on 6% gels, followed by fluorography. Exposure time of 
lane 1 was 21 days for lane 2 it was 7 days. 
pro-vWF. This may be due to the fact that these enzymes 
are thought to be involved in the processing of proteins in 
the regulated secretion pathway [40,41], a pathway not 
present in PK(15) cells. Coexpression of pro-LPH with 
HuPACE4 and MoPC6A resulted in substantial cleavage 
of pro-vWF. 
In conclusion, cotransfection of human pro-LPH with 
the different members of the furin family of proprotein 
processing enzymes in PK(15) cells did not result in 
cleavage of pro-LPH. As proprotein synthesis and secre- 
tion were functional in PK(15) as illustrated with vWF, 
and the pro-LPH species expressed under the experimental 
conditions used corresponded to those in intestinal epithe- 
202 M. Wiithrich et al. /Biochimica et Biophysica Acta 1311 (1996) 199-203 
MW 
o ~ < 
: £- £ z - r  -I- 
4" 4" 4" 4" '4" 
[ '-- > > > 
2 0 0  k D a  
p r o - v W F  
m - v W F  
1 2 3 4 5 6 7 
Fig. 2. Analysis of proteolytic processing of pro-vWF by subtilisin-like 
proteases. After infection of PK (15) cells with V.V.:T7 virus, cells were 
infected by pGEM7zf + plasmid coding for pro-yon Willebrand factor 
(pro-vWF). Newly synthesized proteins were labelled with 
[35S]methionine for 30 min and chased for 4 h. T7: infected PK (15) cells 
do not express vWF-related protein (lane 1). vWF: transfected cells 
produce mainly pro-vWF (lane 2). Co-expression of vWF with the 
proteases human furin (lane 3), human PCI/PC3 (lane 4), human PC2 
(lane 5), human PACE4 (lane 6) and mouse PC6A (lane 7) resulted in a 
different processing pattern. The relative positions of pro-vWF and 
mature vWF are indicated. 
lial cells, it can further be concluded, that the investigated 
proprotein processing proteases are not involved in the 
maturation of human LPH. 
The family of subtilisin-like enzymes is a growing one. 
It can not be excluded that other members of the family 
may be involved in the maturation of human LPH. 
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